Chicago Partners Investment Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Chicago Partners Investment Group’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,065	Closed	-$179K	–	629
2021 Q3	$179K	Buy	+10,065	New	+$118K	0.01%	556
2021 Q2	–	Sell	-10,948	Closed	-$104K	–	568
2021 Q1	$104K	Buy	+10,948	New	+$135K	0.01%	510

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Chicago Partners Investment Group's TRIL Position: Q4 2021 in Review

Chicago Partners Investment Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 10,065 shares — an estimated $179K sold.

Chicago Partners Investment Group first reported a position in TRIL in Q1 2021 and held it in 2 quarters. The position peaked at $179K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Chicago Partners Investment Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Chicago Partners Investment Group sold 10,065 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $179K.
Chicago Partners Investment Group first reported a position in Trillium Therapeutics Inc. in Q1 2021 and held it in 2 quarters.
Chicago Partners Investment Group's Trillium Therapeutics Inc. position peaked at $179K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Chicago Partners Investment Group's 13F filing for Q4 2021, filed 15 Feb 2022.